Clinical trials
Terminated Phase 2 Lymphoma, T-Cell, Peripheral trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Affimed GmbH | 1 |
| Alaunos Therapeutics | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Karyopharm Therapeutics Inc | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mahidol University | 1 |
| Seagen Inc. | 1 |
| Seoul National University Hospital | 1 |
| University of Bologna | 1 |
| University of California, San Francisco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 11 |
| Lymphoma | 3 |
| Lymphoma, Large-Cell, Anaplastic | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Lymphoma, T-Cell, Cutaneous | 3 |
| Hodgkin Disease | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Lymphoma, T-Cell | 2 |
| Bone Marrow Neoplasms | 1 |
| Burkitt Lymphoma | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.